HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hobson-Peters, J. Articles by Hall, R. A. Search for Related Content PubMed PubMed Citation Articles by Hobson-Peters, J. Articles by Hall, R. A. Agricola Articles by Hobson-Peters, J. Articles by Hall, R. A.

A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection

Philip Toye^2,

Melissa D. Sánchez^4,

David C. Clark^1,

¹ School of Molecular and Microbial Sciences, The University of Queensland, St Lucia, Queensland 4072, Australia
² AGEN Biomedical Limited, Acacia Ridge, Queensland, Australia
³ Australian Biosecurity CRC for Emerging Infectious Disease, St Lucia, Queensland, Australia
⁴ Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
⁵ CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria, Australia

Correspondence
Roy A. Hall
roy.hall{at}uq.edu.au
Philip Toye
p.toye{at}cgiar.org

Using a monoclonal antibody directed to domain I of the West Nile virus (WNV) envelope (E) protein, we identified a continuous (linear) epitope that was immunogenic during WNV infection of horses. Using synthetic peptides, this epitope was mapped to a 19 aa sequence (WN19: E147–165) encompassing the WNV NY99 E protein glycosylation site at position 154. The inability of WNV-positive horse and mouse sera to bind the synthetic peptides indicated that glycosylation was required for recognition of peptide WN19 by WNV-specific antibodies in sera. N-linked glycosylation of WN19 was achieved through expression of the peptide as a C-terminal fusion protein in mammalian cells and specific reactivity of WNV-positive horse sera to the glycosylated WN19 fusion protein was shown by Western blot. Additional sera collected from horses infected with Murray Valley encephalitis virus (MVEV), which is similarly glycosylated at position E154 and exhibits high sequence identity to WNV NY99 in this region, also recognized the recombinant peptide. Failure of most WNV- and MVEV-positive horse sera to recognize the epitope as a deglycosylated fusion protein confirmed that the N-linked glycan was important for antibody recognition of the peptide. Together, these results suggest that the induction of antibodies to the WN19 epitope during WNV infection of horses is generally associated with E protein glycosylation of the infecting viral strain.

Present address: The International Livestock Research Institute, PO Box 30709, Nairobi 00100, Kenya.

Present address: Department of Pathology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Present address: Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA, USA.

||Present address: Mosquito Control Laboratory, Queensland Institute of Medical Research, Herston, Queensland, Australia.

This article has been cited by other articles:

				R. A. Hall, S. E. Tan, B. Selisko, R. Slade, J. Hobson-Peters, B. Canard, M. Hughes, J. Y. Leung, E. Balmori-Melian, S. Hall-Mendelin, et al. Monoclonal antibodies to the West Nile virus NS5 protein map to linear and conformational epitopes in the methyltransferase and polymerase domains J. Gen. Virol., December 1, 2009; 90(12): 2912 - 2922. [Abstract] [Full Text] [PDF]